LLY 8-K 2026-10-29
ELI LILLY & Co (LLY) 8-K dated 2026-10-29 — accession 0000059478-26-000104. This URL is the filing, not the LLY hub.
ELI LILLY & Co (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
LLY revenue $24.4B
Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 47.6.
Not investment advice. The LLY SEC hub lists recent forms. The stock page is the research view.
- Revenue
- $24.4B
- Guidance
- full-year guidance and highlights regulatory progress across the portfolio
Why it matters
- full-year guidance and highlights regulatory progress across the portfolio
- Lilly had another strong quarter, exceeding our prior expectations and allowing us to raise our full-year outlook,…